The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...
The Food and Drug Administration (FDA) has approved Vykat™ XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback